This study is to evaluate differences in the gut and follicle/scalp microbiome signature in AGA compared to a non-AGA population. Also, to investigate differences in inflammation and other biomarkers in AGA compared to non-AGA population at baseline and after a successful treatment
Inclusion Criteria:
Volunteers in the healthy control panel must satisfy the following criteria:
Volunteers in the AGA panel must satisfy the following criteria:
Exclusion Criteria:
Non-inclusion Criteria:
With no hair loss
With hairloss
Multi-Omics Insights Into Androgenetic Alopecia
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Hair Regeneration in Androgenetic Alopecia
Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.